MLXIPL and hypertriglyceridemia: Therefore, ChREBP, a transcriptional activator of glycolytic and lipogenic genes may play a role in the development of hypertriglyceridemia in FHTG by regulating the secretion of those molecules (Fig. 1) altering the VLDL-particle composition without changing their numbers.